0.35TWD
287.06 MTWD
3.19 BTWD
252.82 M
About SCINOPHARM TAIWAN LTD
Sector
Industry
CEO
Li An Lu
Website
Headquarters
Tainan
Founded
1997
ISIN
TW0001789006
FIGI
BBG0017XSN24
ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. It also provides consulting and biotechnology services.It operates through the following segments: ScinoPharm Taiwan, Ltd., SciAnda (Changshu) Pharmaceuticals Ltd., and Others. The company's products include abiraterone acetate, anastrozole, apixaban, apremilast, atazanavir sulfate, azacitidine, benazepril hydrochloride, bortezomib, capecitabine, celecoxib, cladribine, dantrolene sodium, decitabine, desmopressin acetate, docetaxel anhydrous, docetaxel trihydrate, entecavir, enzalutamide, exemestane, flumazenil, fulvestrant, galantamine, gefitinib, gemcitabine hydrochloride, ondansetron hydrochloride, and paclitaxel. The company was founded on November 11, 1997 and is headquartered in Tainan, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1789 is 28.20 TWD — it has increased by 0.89% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange SCINOPHARM TAIWAN LTD stocks are traded under the ticker 1789.
SCINOPHARM TAIWAN LTD is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
1789 stock is 1.61% volatile and has beta coefficient of 0.45. Check out the list of the most volatile stocks — is SCINOPHARM TAIWAN LTD there?
1789 earnings for the last quarter are 0.04 TWD per share, whereas the estimation was 0.08 TWD resulting in a −50.00% surprise. The estimated earnings for the next quarter are 0.12 TWD per share. See more details about SCINOPHARM TAIWAN LTD earnings.
SCINOPHARM TAIWAN LTD revenue for the last quarter amounts to 660.00 M TWD despite the estimated figure of 780.00 M TWD. In the next quarter revenue is expected to reach 984.50 M TWD.
Yes, you can track SCINOPHARM TAIWAN LTD financials in yearly and quarterly reports right on TradingView.
1789 stock has risen by 2.36% compared to the previous week, the month change is a 6.42% rise, over the last year SCINOPHARM TAIWAN LTD has showed a 2.92% increase.
1789 net income for the last quarter is 157.38 M TWD, while the quarter before that showed 30.72 M TWD of net income which accounts for 412.31% change. Track more SCINOPHARM TAIWAN LTD financial stats to get the full picture.
Today SCINOPHARM TAIWAN LTD has the market capitalization of 22.14 B, it has increased by 1.86% over the last week.
Yes, 1789 dividends are paid annually. The last dividend per share was 0.36 TWD. As of today, Dividend Yield (TTM)% is 1.29%. Tracking SCINOPHARM TAIWAN LTD dividends might help you take more informed decisions.
SCINOPHARM TAIWAN LTD dividend yield was 1.14% in 2023, and payout ratio reached 82.64%. The year before the numbers were 1.41% and 80.59% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1789 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SCINOPHARM TAIWAN LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SCINOPHARM TAIWAN LTD technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SCINOPHARM TAIWAN LTD stock shows the buy signal. See more of SCINOPHARM TAIWAN LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SCINOPHARM TAIWAN LTD future price: according to them, 1789 price has a max estimate of 27.00 TWD and a min estimate of 27.00 TWD. Read a more detailed SCINOPHARM TAIWAN LTD forecast: see what analysts think of SCINOPHARM TAIWAN LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SCINOPHARM TAIWAN LTD EBITDA is 775.66 M TWD, and current EBITDA margin is 24.35%. See more stats in SCINOPHARM TAIWAN LTD financial statements.